Peripheral Blood Mononuclear Cell-Related Biomarkers in Schizophrenia.
| Autor: | Astafeva D; International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, 78 Nagornaya Street, 443016 Samara, Russia, dashasumburova@gmail.com., Gonda X, Ossina N, Volova L, Sheyfer M, Strelnik A, Lyamin A, Ashurov Z, Syunyakov T, Smirnova D |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Psychiatria Danubina [Psychiatr Danub] 2023 Oct; Vol. 35 (Suppl 2), pp. 114-122. |
| Abstrakt: | Introduction: Schizophrenia is a severe mental illness causing significant impairment in personal, family, social, educational, occupational, and other important areas of life. While there is no widely accepted endophenotype, peripheral blood cells may serve as an accessible model of intracellular changes in schizophrenia. Methods: We reviewed the literature on the query "peripheral blood mononuclear cells AND schizophrenia" in Medline (Pubmed), selecting studies that searched for specific biomarkers of schizophrenia. We considered both diagnostic biomarkers and biomarkers of therapeutic response, specific schizophrenia disorders or differential diagnostic biomarkers. Results: We retrieved 41 articles matching the search criteria, among which were studies that considered changes in the production of pro-inflammatory and anti-inflammatory markers, proteins, receptors, enzyme activity, and gene expression as potential biomarkers. Conclusion: Approaches analysing a biological axis or a group of related biomarkers may hold the greatest promise for identifying schizophrenia. In addition, pharmacological status, smoking status, inflammatory markers and glucose metabolites, the presence of comorbidities should be considered. Certain biomarkers, while not specific for the diagnosis of schizophrenia, may indicate the prognosis and effectiveness of treatment in the established diagnosis. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|